Healthcare | September 24, 2025
Zydus, Pinkathon to drive awareness on breast cancer across India
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Zydus Pinkathon will be led by women to raise awareness on breast cancer and women's health
Alkem's Pertuza is an affordable, indigenously-developed and manufactured biosimilar of pertuzumab
Hengrui is eligible to receive regulatory and commercial milestone payments of up to US$1.093 billion
Importantly, the combination of giredestrant and everolimus was well tolerated
Keytruda Qlex is the first and only subcutaneously administered immune checkpoint inhibitor that can be given by a health care provider in as little as one minute
Encouraging early detection and breaking the silence around men’s health
Raludotatug deruxtecan is a specifically engineered, potential first-in-class CDH6-directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo
Treatment with Verzenio also resulted in sustained invasive disease-free survival and distant relapse-free survival benefit
The AI system was tested on digital slides from breast, colon, stomach, and esophageal cancer cases
Fourteenth breakthrough therapy designation granted by FDA across the oncology portfolio of Daiichi Sankyo
Subscribe To Our Newsletter & Stay Updated
